RT @CochraneLibrary: 👀💊 Rho kinase inhibitors for primary open-angle #glaucoma and ocular hypertension 🎧 Listen to the #CochranePodcast ht…
RT @CochraneLibrary: 👀💊 Rho kinase inhibitors for primary open-angle #glaucoma and ocular hypertension 🎧 Listen to the #CochranePodcast ht…
RT @CochraneLibrary: 👀💊 Rho kinase inhibitors for primary open-angle #glaucoma and ocular hypertension 🎧 Listen to the #CochranePodcast ht…
RT @CochraneUK: 👀 💊 Rho kinase inhibitors for primary open-angle #glaucoma and ocular hypertension 🎧 Listen to the #CochranePodcast https:/…
RT @CochraneEyes: New Cochrane Review on Rho kinase inhibitor for primary open-angle #glaucoma and ocular hypertension https://t.co/XcvGixb…
RT @GoodluckJBers14: #CochraneDaily Josefine Freiberg from University of Copenhagen tells you about her new @CochraneCollab Review of rho k…
RT @GoodluckJBers14: #CochraneDaily Josefine Freiberg from University of Copenhagen tells you about her new @CochraneCollab Review of rho k…
#CochraneDaily Josefine Freiberg from University of Copenhagen tells you about her new @CochraneCollab Review of rho kinase inhibitors for treating glaucoma in <5 minutes at https://t.co/p89goMxrba or read the full review at https://t.co/ajfCnUKsSV @Co
👀💊 Rho kinase inhibitors for primary open-angle #glaucoma and ocular hypertension 🎧 Listen to the #CochranePodcast https://t.co/Zlu7wbzuG9 🌟 Also on @Spotify & @ApplePodcasts 📚 Based on the @CochraneEyes systematic review: https://t.co/xNbLwXM1OW ht
RT @CochraneEyes: New Cochrane Review on Rho kinase inhibitor for primary open-angle #glaucoma and ocular hypertension https://t.co/XcvGixb…
RT @CochraneEyes: New Cochrane Review on Rho kinase inhibitor for primary open-angle #glaucoma and ocular hypertension https://t.co/XcvGixb…
RT @CochraneEyes: New Cochrane Review on Rho kinase inhibitor for primary open-angle #glaucoma and ocular hypertension https://t.co/XcvGixb…
RT @CochraneEyes: New Cochrane Review on Rho kinase inhibitor for primary open-angle #glaucoma and ocular hypertension https://t.co/XcvGixb…
RT @CochraneEyes: New Cochrane Review on Rho kinase inhibitor for primary open-angle #glaucoma and ocular hypertension https://t.co/XcvGixb…
New Cochrane Review on Rho kinase inhibitor for primary open-angle #glaucoma and ocular hypertension https://t.co/XcvGixbFqj #GlaucomaAwarenessWeek @UCPH_Research @Moorfields @RCOphth https://t.co/dnFxCaGsvj